Portfolio News

OmniLife Named Winner of the 2022 Lyfebulb-CVS Kidney Care® Innovation Challenge

Lyfebulb, a patient-empowerment platform that connects patients with industry experts to support user-driven innovation, and CVS Kidney Care®, a CVS Health® company, are excited to announce that OmniLife was selected as the winner, and Kindness for Kidneys International received an honorable mention, at the 2022 Lyfebulb–CVS Kidney Care® Innovation Challenge: Accelerating Innovations in Kidney Disease to Improve Health Equity and Outcomes. Read more >>
Read more...

CleanFiber secures $14 million for Lackawanna expansion

A past 43North winner is expanding again after securing $14 million in debt financing. Five years after the company moved to Buffalo, CleanFiber now employs more than 70 people in its Lackawanna factory. The funding will support the addition of new equipment that allows the company to fulfill the demand for its product. “We’ve had a significant uptick in hiring that’s been driven by growth and demand,” CEO Jonathan Strimling said. “We have a long backlog of demand for our...
Read more...

Michael Bayer: ‘CFOs Are Storytellers’

Michael Bayer, CFO of Wasabi Technologies, asked this rhetorical question in response to CFO’s inquiry about the business outlook for his company and cloud storage. In preparation for this week’s CFO Leadership Council Conference, we took the opportunity to ask Bayer to reflect on his own career in finance and how his organizational structure empowers Wasabi to greater opportunities. Read more >>
Read more...

Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today it dosed the first set of volunteers in an open-label study of AKS-452, its protein subunit COVID-19 vaccine, as a booster. The Phase II booster study is designed to investigate the response of the immune system in up to 600 volunteers who have previously been vaccinated with EMA-registered vaccines from Pfizer, Moderna, Johnson & Johnson (Janssen) and AstraZeneca. The study is being conducted at the University Medical...
Read more...

US Veterans and Injured Workers Find Injury Solution With sam® Sustained Acoustic Medicine Treatment

Sustained acoustic medicine, or sam®, is a non-invasive ultrasound device from ZetrOZ Systems used to treat soft tissue injuries and arthritis. The U.S. Federal Drug Administration cleared sam® for clinical use in 2013, but many health care providers are just now discovering the many benefits it provides to treatment and recovery efforts. The sam® pain relief device has helped thousands of patients, including U.S. Veterans and Active Duty Members, regain mobility and reduce pain from common overuse injuries and osteoarthritis....
Read more...

Wasabi Technologies Opens Storage Region in Sydney

Wasabi Technologies, the hot cloud storage company, has opened its 12th global storage region, located in Sydney, Australia, to help organizations in the Asia Pacific region capitalize on the growing adoption of hybrid cloud and digital-first infrastructure, while also addressing data sovereignty. Sydney is the latest in Wasabi's expansive international rollout. In 2021, the company opened APAC headquarters in Tokyo and a short time later launched a storage region in Osaka. This year, Wasabi began service in Toronto, Frankfurt, Paris,...
Read more...

OmniLife Receives $250,000 SBIR Grant in Support of Transplants for Kids project

OmniLife, a health technology communication and collaboration platform, and collaborators Children’s Hospital of Pittsburgh and the Starzl Network have been awarded a $250,000 SBIR grant from the National Institutes of Health. The grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will support the “Transplants for Kids” project, which will use AI / machine learning algorithms to align optimal donor grafts with children awaiting liver transplants. Previous work completed by members of the Starzl Network and...
Read more...

#ThinkBeforeYouClick: Wasabi’s IT Hero Nate Returns to Warn About the Dangers of Ransomware

  Ransomware can be lurking anywhere. Education is the best defense against attacks. But when that fails, there’s always Wasabi. Don’t let the cybercriminals win. With cybercriminals extorting millions of dollars from organizations every year, ransomware is not going away any time soon. Protect yourself with proven security best practices, including regular ransomware awareness training and a robust backup and recovery strategy with immutable cloud storage. Click happens. But you don’t have to lose your data over it.
Read more...

INVEST Pitch Perfect winner: myBiometry aims to prevent asthma attacks long before they happen

Nationwide, more than 25 million people have asthma, including about 20 million adults and 5.1 million children and adolescents. If not well-controlled, the chronic condition can cause airways to swell and narrow, making it hard to breathe. This is called an asthma attack, and in a single year, more than 10 million people have one, according to the Centers for Disease Control and Prevention, resulting in 1.6 million emergency room visits and over 3,500 deaths. Now a Boston-based startup, myBiometry, is...
Read more...